The stock of Tango Therapeutics Inc (NASDAQ:TNGX) last traded at $2.83, down -12.65% from the previous session.
TNGX stock price is now -62.62% away from the 50-day moving average and -67.82% away from the 200-day moving average. The market capitalization of the company currently stands at $303.22M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $19, Jefferies recently initiated with Buy rating for Tango Therapeutics Inc (NASDAQ: TNGX). , while ‘Piper Sandler’ rates the stock as ‘Overweight’
In other news, Boxer Capital Management, LLC, sold 3,080,000 shares of the company’s stock on Nov 06 ’24. The stock was sold for $9,671,200 at an average price of $3.14. Upon completion of the transaction, the now directly owns 3,610,642 shares in the company, valued at $10.22 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 06 ’24, Member of group formerly ownin Boxer Capital Management, LLC bought 575,000 shares of the business’s stock. A total of $2,978,500 was incurred on buying the stock at an average price of $5.18. A total of 44.83% of the company’s stock is owned by insiders.
During the past 12 months, Tango Therapeutics Inc has had a low of $2.91 and a high of $13.01. As of last week, the company has a debt-to-equity ratio of 0.16, a current ratio of 8.00, and a quick ratio of 8.00. The fifty day moving average price for TNGX is $7.7417 and a two-hundred day moving average price translates $8.842475 for the stock.
The latest earnings results from Tango Therapeutics Inc (NASDAQ: TNGX) was released for 2024-06-30. The net profit margin was -284.43% and return on equity was -48.80% for TNGX. The company reported revenue of $11.61 million for the quarter, compared to $10.73 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 8.15 percent.
